Is OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) a Long Term Growth Play? Shares have moved -2.32% YTD

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) has been recommended as a long term growth pick according to Beta Research.  With their stock price currently trading around $0.73, the firm has proven a solid track record of growth over the past few years.  Investors might consider the stock as a long term growth candidate as the firm has yielded 45.00% earnings per share growth over the past 5 years and 9.10% revenue growth over that same time frame. 

Some investors may be bemoaning the stock choices they have made over the last year. Crafting a detailed plan may help with turning things around. The stock market is still running at high levels and investors need to be able to make every trade count. The next couple of weeks may be a great time for investors to review the portfolio and make some adjustments for the last few months of the year. Most investors realize that there are no certainties when it comes to stock market investing. Investors who make the proper preparations and put in the extra time may be able to get themselves headed on the right track to realizing profits.  

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED)’s stock was -2.32%.  Over the last week of the month, it was -3.12%, -57.31% over the last quarter, and  -69.58% for the past six months. 

Over the past 50 days, OncoMed Pharmaceuticals, Inc.’s stock is -46.90% off of the high and 33.52% removed from the low.  Their 52-Week High and Low are as follows: -79.83% (High), 33.52%, (Low). 

Despite the past success, investors want to know where the stock is headed from here.  Analysts covering the shares have a consensus short-term price target of $1.50 on the equity.   Analysts have a consensus recommendation of 3.00 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  

At times, stock market volatility can wreak havoc on investors. When the market becomes highly volatile, investors may get the jitters and think they need to rush to action. In the heat of the moment, it can be tricky to see the clear skies in the distance. Investors may be best served at times to just let the cards fall where they may and not try to be a hero and drastically change the portfolio. Following a solid plan may allow investors to lay off the gas when times get tough. If the research is well done and the plan is in place, sticking to the plan might be the call. Of course nobody wants to see a significant drop in the value of stocks that they own. Being able to see the overall picture when the markets become turbulent may allow the investor to move forward with confidence.

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.